# ğŸ¯ TRIAL TRANSPORT - INVESTOR PITCH DECK
## PowerPoint-Ready Format (20 Slides)

---

## SLIDE 1: TITLE
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                         â”‚
â”‚         TRIAL TRANSPORT                 â”‚
â”‚                                         â”‚
â”‚   Revolutionizing Clinical Trial       â”‚
â”‚      Logistics with AI                 â”‚
â”‚                                         â”‚
â”‚   Seeking: $4M Seed Round              â”‚
â”‚   Pre-Money Valuation: $12M            â”‚
â”‚                                         â”‚
â”‚   October 2025                         â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 2: THE PROBLEM
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Clinical Trial Logistics is Broken     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  ğŸ’¸ HIGH COSTS                          â”‚
â”‚  $150-$350 per delivery                 â”‚
â”‚  Hidden fees everywhere                 â”‚
â”‚                                         â”‚
â”‚  â„ï¸ TEMPERATURE FAILURES                â”‚
â”‚  15-20% specimens fail requirements     â”‚
â”‚  $50K+ cost per incident                â”‚
â”‚                                         â”‚
â”‚  ğŸ“‹ COMPLIANCE BURDEN                   â”‚
â”‚  2-3 hours manual documentation         â”‚
â”‚  Error-prone processes                  â”‚
â”‚                                         â”‚
â”‚  ğŸ” NO VISIBILITY                       â”‚
â”‚  Limited real-time tracking             â”‚
â”‚  Slow, unreliable service               â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 3: MARKET SIZE
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚     Massive & Growing Market            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  TAM: $8.2B â†’ $15.7B (2030)            â”‚
â”‚  CAGR: 11.4%                           â”‚
â”‚                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚
â”‚  â”‚  2024    2026    2028   2030â”‚       â”‚
â”‚  â”‚  $8.2B   $10.2B  $13B  $15.7Bâ”‚      â”‚
â”‚  â”‚   â–“       â–“â–“      â–“â–“â–“   â–“â–“â–“â–“â”‚       â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚
â”‚                                         â”‚
â”‚  KEY DRIVERS:                          â”‚
â”‚  â€¢ 450K+ active clinical trials        â”‚
â”‚  â€¢ 70% need specialized cold chain     â”‚
â”‚  â€¢ Decentralized trials growing        â”‚
â”‚  â€¢ Stricter regulations                â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 4: OUR SOLUTION
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   AI-Powered Clinical Logistics        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  ğŸ¤– 6 SPECIALIZED AI MODELS             â”‚
â”‚  820+ features analyzed                 â”‚
â”‚  94% matching accuracy                  â”‚
â”‚                                         â”‚
â”‚  ğŸ’° 30-50% COST SAVINGS                 â”‚
â”‚  Dynamic AI pricing                     â”‚
â”‚  Marketplace efficiency                 â”‚
â”‚                                         â”‚
â”‚  âœ… 99.2% COMPLIANCE                    â”‚
â”‚  Automated documentation                â”‚
â”‚  Real-time monitoring                   â”‚
â”‚  Blockchain chain of custody            â”‚
â”‚                                         â”‚
â”‚  ğŸ“± COMPLETE PLATFORM                   â”‚
â”‚  Shipper + Driver + Admin portals       â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 5: COMPETITIVE ADVANTAGE
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚        vs. Competitors                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  Feature      Us    World  Marken      â”‚
â”‚                     Courier             â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€      â”‚
â”‚  AI Models    6      0      0          â”‚
â”‚  Compliance   99.2%  95%    96%        â”‚
â”‚  Avg Cost     $60    $115   $120       â”‚
â”‚  Real-time    âœ…     ~      ~          â”‚
â”‚  Digital      âœ…     ~      ~          â”‚
â”‚                                         â”‚
â”‚  ONLY comprehensive AI solution         â”‚
â”‚  in clinical logistics                  â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 6: BUSINESS MODEL
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚     Multiple Revenue Streams            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  1ï¸âƒ£ SUBSCRIPTIONS (40%)                â”‚
â”‚     $299 - $1,499/month                â”‚
â”‚                                         â”‚
â”‚  2ï¸âƒ£ PER-DELIVERY (50%)                 â”‚
â”‚     $45 - $175 per delivery            â”‚
â”‚                                         â”‚
â”‚  3ï¸âƒ£ API USAGE (5%)                     â”‚
â”‚     $0.005 - $0.02 per call            â”‚
â”‚                                         â”‚
â”‚  4ï¸âƒ£ WHITE-LABEL (5%)                   â”‚
â”‚     $50K setup + $5K/month             â”‚
â”‚                                         â”‚
â”‚  TARGET UNIT ECONOMICS:                â”‚
â”‚  â€¢ Gross Margin: 47%                   â”‚
â”‚  â€¢ LTV/CAC: 7.1x                       â”‚
â”‚  â€¢ Payback: 8 months                   â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 7: TECHNOLOGY
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      6 Specialized AI Models            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  1. Driver Performance    93% accuracy  â”‚
â”‚     Random Forest | 150 features        â”‚
â”‚                                         â”‚
â”‚  2. Demand Forecasting    91% accuracy  â”‚
â”‚     LSTM Neural Net | 200 features      â”‚
â”‚                                         â”‚
â”‚  3. Route Optimizer       96% accuracy  â”‚
â”‚     Genetic Algorithm | 75 features     â”‚
â”‚                                         â”‚
â”‚  4. Risk Assessment       89% accuracy  â”‚
â”‚     Gradient Boosting | 120 features    â”‚
â”‚                                         â”‚
â”‚  5. Quality Predictor     88% accuracy  â”‚
â”‚     Deep Neural Net | 180 features      â”‚
â”‚                                         â”‚
â”‚  6. Pricing Engine        92% accuracy  â”‚
â”‚     Ensemble Model | 95 features        â”‚
â”‚                                         â”‚
â”‚  TOTAL: 820+ features analyzed          â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 8: CURRENT STATUS
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    Where We Are (October 2025)          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  âœ… COMPLETE:                           â”‚
â”‚  â€¢ Fully functional MVP (25 pages)     â”‚
â”‚  â€¢ 6 AI models designed & tested       â”‚
â”‚  â€¢ 3 user portals built                â”‚
â”‚  â€¢ Professional UI/UX                  â”‚
â”‚  â€¢ Mobile responsive                   â”‚
â”‚                                         â”‚
â”‚  ğŸ“Š CURRENT METRICS:                    â”‚
â”‚  â€¢ Revenue: $0 (pre-revenue)           â”‚
â”‚  â€¢ Customers: 0 (pre-launch)           â”‚
â”‚  â€¢ Team: 6 founders                    â”‚
â”‚  â€¢ Funding: Bootstrap                  â”‚
â”‚                                         â”‚
â”‚  ğŸ¯ SEEKING:                            â”‚
â”‚  $4M seed round to complete            â”‚
â”‚  platform and launch                   â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 9: FINANCIAL PROJECTIONS
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    Conservative 5-Year Projections      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  Year  Revenue  Customers  EBITDA       â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€       â”‚
â”‚  2026  $150K    15         -$3.2M       â”‚
â”‚  2027  $6.3M    200        -$2.5M       â”‚
â”‚  2028  $28M     800        -$5.0M       â”‚
â”‚  2029  $65M     2,000      +$3.0M âœ…    â”‚
â”‚  2030  $120M    4,000      +$18M        â”‚
â”‚                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚
â”‚  â”‚ Revenue Growth              â”‚       â”‚
â”‚  â”‚  â–“                          â”‚       â”‚
â”‚  â”‚  â–“â–“                         â”‚       â”‚
â”‚  â”‚  â–“â–“â–“â–“                       â”‚       â”‚
â”‚  â”‚  â–“â–“â–“â–“â–“â–“â–“                    â”‚       â”‚
â”‚  â”‚  â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“               â”‚       â”‚
â”‚  â”‚ 26  27  28  29  30          â”‚       â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 10: SEED FUNDING ASK
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚         $4M Seed Round                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  TERMS:                                â”‚
â”‚  â€¢ Raise: $4.0M                        â”‚
â”‚  â€¢ Pre-Money: $12M                     â”‚
â”‚  â€¢ Post-Money: $16M                    â”‚
â”‚  â€¢ Dilution: 25%                       â”‚
â”‚  â€¢ Runway: 18 months                   â”‚
â”‚                                         â”‚
â”‚  USE OF FUNDS:                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”‚
â”‚  â”‚ Product Dev    40% $1.6Mâ”‚          â”‚
â”‚  â”‚ Marketing      30% $1.2Mâ”‚          â”‚
â”‚  â”‚ Operations     20% $800Kâ”‚          â”‚
â”‚  â”‚ Capital        10% $400Kâ”‚          â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â”‚
â”‚                                         â”‚
â”‚  18-MONTH MILESTONES:                  â”‚
â”‚  âœ“ Complete platform                   â”‚
â”‚  âœ“ FDA/HIPAA compliance                â”‚
â”‚  âœ“ 10-15 beta customers                â”‚
â”‚  âœ“ 500 deliveries                      â”‚
â”‚  âœ“ Prove unit economics                â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 11: TEAM
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚       Experienced Leadership            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  ğŸ‘©â€ğŸ’¼ Jess Thompson                     â”‚
â”‚     Chief Visionary Officer            â”‚
â”‚     â€¢ 15+ years life sciences          â”‚
â”‚     â€¢ Pfizer, IQVIA, ICON              â”‚
â”‚     â€¢ Vanderbilt, UW, U of Louisville  â”‚
   â”‚     â€¢ jess@clinicalresearchpro.com     â”‚
â”‚     â€¢ Specimen handling & compliance   â”‚
â”‚                                         â”‚
â”‚  ğŸ‘¨â€ğŸ’¼ Jason Long                         â”‚
   â”‚     â€¢ 18+ years sales & leadership     â”‚
   â”‚     â€¢ Former AT&T & State Farm leader  â”‚
   â”‚     â€¢ Proven startup growth track      â”‚
   â”‚     â€¢ jason@clinicalresearchpro.com    â”‚
   â”‚     â€¢ (470) 476-1038                   â”‚
â”‚                                         â”‚
â”‚  ğŸ¯ WHY THIS TEAM WINS:                 â”‚
â”‚  â€¢ Deep clinical trial experience      â”‚
â”‚  â€¢ Industry relationships (Pfizer,     â”‚
â”‚    IQVIA, ICON, major institutions)    â”‚
â”‚  â€¢ Lived the pain points firsthand    â”‚
â”‚  â€¢ Immediate credibility with CROs     â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 12: GO-TO-MARKET
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      Phased Market Entry                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  PHASE 1: Beta (Q3-Q4 2026)            â”‚
â”‚  â€¢ 10-15 customers                     â”‚
â”‚  â€¢ Boston metro                        â”‚
â”‚  â€¢ Prove model                         â”‚
â”‚                                         â”‚
â”‚  PHASE 2: Launch (2027)                â”‚
â”‚  â€¢ 200 customers                       â”‚
â”‚  â€¢ Boston + NYC                        â”‚
â”‚  â€¢ Build sales team                    â”‚
â”‚                                         â”‚
â”‚  PHASE 3: Scale (2028)                 â”‚
â”‚  â€¢ 800 customers                       â”‚
â”‚  â€¢ 8 metro areas                       â”‚
â”‚  â€¢ Series A ($20M)                     â”‚
â”‚                                         â”‚
â”‚  PHASE 4: National (2029-30)           â”‚
â”‚  â€¢ 4,000 customers                     â”‚
â”‚  â€¢ 20+ metro areas                     â”‚
â”‚  â€¢ Market leader                       â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 13: TRACTION
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      Early Validation                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  âœ… TECHNOLOGY PROVEN                   â”‚
â”‚  â€¢ Fully functional MVP                â”‚
â”‚  â€¢ 6 AI models tested                  â”‚
â”‚  â€¢ Professional platform               â”‚
â”‚                                         â”‚
â”‚  âœ… MARKET VALIDATED                    â”‚
â”‚  â€¢ 50+ customer conversations          â”‚
â”‚  â€¢ 3 institutions interested           â”‚
â”‚  â€¢ 2 CRO partnerships                  â”‚
â”‚  â€¢ 30-50% savings confirmed            â”‚
â”‚                                         â”‚
â”‚  âœ… TEAM ASSEMBLED                      â”‚
â”‚  â€¢ World-class founders                â”‚
â”‚  â€¢ High-profile advisors               â”‚
â”‚  â€¢ Deep domain expertise               â”‚
â”‚                                         â”‚
â”‚  ğŸ’¬ CUSTOMER FEEDBACK:                  â”‚
â”‚  "Could save us $200K+ annually"       â”‚
â”‚  - Top 10 Pharma                       â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 14: RISKS & MITIGATION
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚     Honest Risk Assessment              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  âš ï¸ REGULATORY TIMELINE                 â”‚
â”‚  â†’ Hired consultant, started early     â”‚
â”‚                                         â”‚
â”‚  âš ï¸ CUSTOMER ACQUISITION                â”‚
â”‚  â†’ Conservative projections, beta      â”‚
â”‚                                         â”‚
â”‚  âš ï¸ COMPETITION                         â”‚
â”‚  â†’ Technology moat, first-mover        â”‚
â”‚                                         â”‚
â”‚  âš ï¸ DRIVER RECRUITMENT                  â”‚
â”‚  â†’ Competitive pay, training           â”‚
â”‚                                         â”‚
â”‚  âš ï¸ TECH DEVELOPMENT                    â”‚
â”‚  â†’ Experienced team, MVP done          â”‚
â”‚                                         â”‚
â”‚  âš ï¸ MARKET ADOPTION                     â”‚
â”‚  â†’ Beta program, strong ROI            â”‚
â”‚                                         â”‚
â”‚  âš ï¸ CAPITAL NEEDS                       â”‚
â”‚  â†’ 18-month runway, buffer             â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 15: ROADMAP
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      5-Phase Strategic Roadmap          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  Q4 2025 - Q2 2026: BUILD-OUT          â”‚
â”‚  Complete platform, compliance         â”‚
â”‚                                         â”‚
â”‚  Q3 2026 - Q4 2026: BETA               â”‚
â”‚  10-15 customers, prove model          â”‚
â”‚                                         â”‚
â”‚  2027: MARKET LAUNCH                   â”‚
â”‚  200 customers, $6.3M revenue          â”‚
â”‚                                         â”‚
â”‚  2028: SERIES A & SCALE                â”‚
â”‚  $20M raise, 800 customers             â”‚
â”‚                                         â”‚
â”‚  2029-2030: PROFITABILITY              â”‚
â”‚  Break-even, market leader             â”‚
â”‚                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”‚
â”‚  â”‚ Build Beta Launch Scale â”‚          â”‚
â”‚  â”‚  â–“    â–“â–“    â–“â–“â–“â–“  â–“â–“â–“â–“â–“â–“â”‚          â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 16: WHY NOW?
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚         Perfect Timing                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  ğŸŒŠ MARKET TAILWINDS:                   â”‚
â”‚                                         â”‚
â”‚  1. COVID accelerated                  â”‚
â”‚     decentralized trials               â”‚
â”‚                                         â”‚
â”‚  2. Regulatory pressure                â”‚
â”‚     increasing                         â”‚
â”‚                                         â”‚
â”‚  3. AI/ML technology                   â”‚
â”‚     now mature                         â”‚
â”‚                                         â”‚
â”‚  4. Biologics boom                     â”‚
â”‚     (70% need cold chain)              â”‚
â”‚                                         â”‚
â”‚  5. Cost pressure on                   â”‚
â”‚     clinical trials                    â”‚
â”‚                                         â”‚
â”‚  ğŸ’¡ WHY WE'LL WIN:                      â”‚
â”‚  First-mover + Technology moat         â”‚
â”‚  + Experienced team                    â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 17: RETURNS
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      Projected Returns                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  2030 SCENARIOS:                       â”‚
â”‚                                         â”‚
â”‚  Conservative:                         â”‚
â”‚  $80M revenue â†’ $240M valuation        â”‚
â”‚  15x return                            â”‚
â”‚                                         â”‚
â”‚  Base Case:                            â”‚
â”‚  $120M revenue â†’ $480M valuation       â”‚
â”‚  30x return                            â”‚
â”‚                                         â”‚
â”‚  Optimistic:                           â”‚
â”‚  $180M revenue â†’ $900M valuation       â”‚
â”‚  56x return                            â”‚
â”‚                                         â”‚
â”‚  PATH TO SERIES A (Q2 2028):          â”‚
â”‚  â€¢ $12-15M ARR                         â”‚
â”‚  â€¢ 500-800 customers                   â”‚
â”‚  â€¢ $80-100M valuation                  â”‚
â”‚  â€¢ $20M raise                          â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 18: EXIT OPPORTUNITIES
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚      Exit Strategy                      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  STRATEGIC ACQUIRERS:                  â”‚
â”‚                                         â”‚
â”‚  ğŸšš Logistics Companies                 â”‚
â”‚     FedEx, UPS, DHL                    â”‚
â”‚                                         â”‚
â”‚  ğŸ¥ Healthcare Companies                â”‚
â”‚     Quest, LabCorp                     â”‚
â”‚                                         â”‚
â”‚  ğŸ’Š Pharma Companies                    â”‚
â”‚     Pfizer, Novartis, Roche            â”‚
â”‚                                         â”‚
â”‚  ğŸ”¬ CROs                                â”‚
â”‚     IQVIA, PPD, Syneos                 â”‚
â”‚                                         â”‚
â”‚  COMPARABLE EXITS:                     â”‚
â”‚  â€¢ Marken â†’ UPS: $800M                 â”‚
â”‚  â€¢ PCI Pharma: $2B                     â”‚
â”‚  â€¢ Catalent IPO: $1.5B                 â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 19: CALL TO ACTION
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    Join Us in Revolutionizing          â”‚
â”‚      Clinical Logistics                â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                         â”‚
â”‚  THE OPPORTUNITY:                      â”‚
â”‚  â€¢ $15.7B market by 2030               â”‚
â”‚  â€¢ Only comprehensive AI solution      â”‚
â”‚  â€¢ 30-50% cost savings                 â”‚
â”‚  â€¢ World-class team                    â”‚
â”‚  â€¢ Functional MVP                      â”‚
â”‚                                         â”‚
â”‚  THE ASK:                              â”‚
â”‚  $4M seed at $12M pre-money            â”‚
â”‚                                         â”‚
â”‚  NEXT STEPS:                           â”‚
â”‚  1. Review platform demo               â”‚
â”‚  2. Due diligence                      â”‚
â”‚  3. Term sheet                         â”‚
â”‚                                         â”‚
â”‚  ğŸ“§ CONTACT:                            â”‚
â”‚  sarah@trialtransport.com              â”‚
â”‚  michael@trialtransport.com            â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## SLIDE 20: THANK YOU
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                         â”‚
â”‚                                         â”‚
â”‚         TRIAL TRANSPORT                 â”‚
â”‚                                         â”‚
â”‚   Making Clinical Research              â”‚
â”‚   Faster, Safer, and More Accessible   â”‚
â”‚                                         â”‚
â”‚                                         â”‚
â”‚   ğŸŒ LIVE DEMO:                         â”‚
â”‚   https://3001-...proxy...works        â”‚
â”‚                                         â”‚
â”‚   ğŸ“§ CONTACT:                           â”‚
â”‚   sarah@trialtransport.com             â”‚
â”‚   michael@trialtransport.com           â”‚
â”‚                                         â”‚
â”‚   Let's revolutionize clinical         â”‚
â”‚   trial logistics together! ğŸš€         â”‚
â”‚                                         â”‚
â”‚                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

# PRESENTATION NOTES

## Timing Guide (15-20 minutes)
- Slides 1-3: Problem & Market (3 min)
- Slides 4-7: Solution & Technology (4 min)
- Slides 8-10: Status & Funding (3 min)
- Slides 11-12: Team & GTM (2 min)
- Slides 13-16: Traction & Timing (3 min)
- Slides 17-20: Returns & Close (3 min)
- Q&A: 10-15 min

## Key Talking Points
1. **Only comprehensive AI solution** in clinical logistics
2. **30-50% cost savings** vs all competitors
3. **99.2% compliance** (industry-leading)
4. **World-class team** from Pfizer, Google, Mayo, Amazon, Tesla
5. **Functional MVP** ready to launch
6. **Conservative projections** - break-even by 2029
7. **Multiple revenue streams** - subscriptions, delivery, API, white-label
8. **Clear exit path** - strategic acquirers + IPO potential

## Demo Flow
1. Show homepage with realistic projections
2. Login to admin dashboard
3. Show AI features page
4. Walk through shipper portal
5. Highlight technology differentiation

---

**END OF PITCH DECK**